Inovio Pharmaceuticals, Inc. (INO) Posts Q1 Loss of 6c/Share
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.19 --0%
EPS Growth %: +60.7%
Financial Fact:
License fee and milestone revenue: 2.33M
Today's EPS Names:
PKE, LNN, More
EPS Growth %: +60.7%
Financial Fact:
License fee and milestone revenue: 2.33M
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
Inovio Pharmaceuticals, Inc. (AMEX: INO) reported Q1 EPS of ($0.06), $0.02 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $2.1 million.
For earnings history and earnings-related data on Inovio Pharmaceuticals, Inc. (INO) click here.
For earnings history and earnings-related data on Inovio Pharmaceuticals, Inc. (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lindsay (LNN) Tops Q3 EPS by 18c, Misses on Revenue
- Rivian raises 2026 delivery outlook after Q2 results top guidance
- Tesla Q2 deliveries crush forecasts at 480,126, erasing backlog concerns
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
